Drug Database
Back to search

Poland· PL-100047903

Noctofer

A lormetazepam product containing lormetazepamum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. The same ATC class is registered in 9 of our 19 countries.

ATC N05CD06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNoctoferATCN05CD06REGISTER NO.PL-100047903PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lormetazepamumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lormetazepam is registered in 9 of 19 countries.

Countries holding a registration under ATC N05CD06 (lormetazepam), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search lormetazepam products by name

Lormetazepam · ATC N05CD06

9 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lormetazepam costs, country by country.

Normalised to the WHO defined daily dose (1 mg), the median price runs from $0.066 in Spain to $0.58 in Switzerland — a ×8.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lormetazepam · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.58
  • FR France$0.068
  • ES Spain$0.066
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Lormetazepamum
Manufacturer
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
Country
Poland (PL)
ATC code
N05CD06
ATC class
Lormetazepam
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990136315
  • gtin
    05909990214693
  • gtin
    05909990221370

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

44 interactions on record for lormetazepam.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lormetazepam against other medicinesHow interaction checks work

Lormetazepam · interactions on record

44 records

44 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lormetazepam in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lormetazepam products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Sedalor
  • Belgium · Loramet, Lormetazepam Eg
  • Cyprus · Aldosomnil, Sedalor
  • Germany · Ergocalm, Sedalam
  • Spain · Aldosomnil, Loramet
  • France · Lormetazepam Arrow
  • United Kingdom (Northern Ireland) · Lormetazepam, Lormetazepam Genus Pharmaceuticals
  • Italy · Axilium, Ipnolor
  • Luxembourg · Loramet, Lormetazepam Eg
  • Malta · Sedalor
  • Netherlands · Lormetazepam Aurobindo, Lormetazepam Prolepha

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/94465fe1-9abb-456a-bd8d-e91dc099e2ff
GET /v1/drugs/94465fe1-9abb-456a-bd8d-e91dc099e2ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "1 mg",
  "packaging": "05909990136315 ¦ Rp ¦ Skasowane ¦ 7154\n20 tabl. w fiolce\n05909990214693 ¦ Rp ¦ Skasowane ¦ 26297\n20 tabl. (1 x 10)\n05909990221370 ¦ Rp ¦ 50364\n20 tabl.",
  "substance": "Lormetazepamum 1 mg",
  "common_name": "Lormetazepamum",
  "pl_product_id": "100047903",
  "pozwolenie_nr": "01363",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about lormetazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console